Today’s ACT Brief explores how eConsent is modernizing participant engagement, highlights new data on global representation in breast cancer trials, and examines Moderna’s decision to halt its Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback